ST. LOUIS, NOVEMBER 28, 2012 – When it comes to using the latest technology in neurosurgery, at least 60 percent of children’s hospitals that ranked among the top 20 pediatric hospitals for neurology and neurosurgery in this year’s U.S. News & World Report use the NICO Myriad brain tumor removal system to address patient outcomes in appropriate cases.
The Myriad is about the size of a pencil and is completely automated, making it the first device that operates in open and endoscopic surgical approaches without using a heat source or ultrasonic energy that can potentially damage delicate critical structures in the brain. Children’s Hospital Los Angeles (CHLA) uses NICO products to assist with its neurosurgery procedures and said it offers improved patient outcomes in a healthcare environment that is rapidly changing.
“Staying ahead of the curve to offer the best medical solutions for our patients requires that we have the best technologies in our hospital,” said Mark Krieger, M.D. division chief of Neurosurgery at CHLA, ranked among the top five children’s hospital in the country in the 2012 U.S. News and World Report Best Children’s Hospitals survey. “In choosing technologies, we consider what offers the best patient outcomes and what gives surgeons the ability to be more efficient and effective in their approaches to doing minimally invasive surgery.”
The Myriad product line is among several medical devices featured at this week’s 41st Annual Meeting of the AANS/CNS Section on Pediatric Neurological Surgery in St. Louis. This year’s theme around safety, efficacy and efficiency in pediatric neurosurgery falls right in line with NICO’s goal of offering safe, effective and efficient technology for the access and removal of tissue abnormalities through narrow surgical corridors. Of the top 20 pediatric neurosurgery hospitals in the U.S. News ranking, 14 use the Myriad.
“We are revolutionizing neurosurgery through the development of new and modern ways to remove tumors and tissue abnormalities from the brain with the least amount of negative impact to the patient,” said Jim Pearson, president and CEO of NICO Corporation. “We are making this happen in less invasive ways that result in minimized trauma and improved recovery metrics. It’s simply better for the patient and meets the demands of the new healthcare environment that expects improved results in both patient care and better hospital economics.”
More than 80 hospitals in the U.S., Canada and Australia have adopted NICO technology and four peer-reviewed clinical papers sharing the positive results of the Myriad have been independently published in neurosurgical journals. NICO Corporation was named after its first patient, Nico Bastolla, a 9-month-old boy who suffered from laughing seizures 18 hours a day from a Hypothalamic Harmartoma tumor. The Myriad was used to remove the pea-sized tumor in 2004. Today, Nico is a healthy 9-year-old who loves playing baseball.
To learn more about NICO Corporation and the Myriad, visit NICO at www.niconeuro.com. View surgical procedure videos using the Myriad and how to download the new NICO App for iPhones on YouTube at NICOneuroCorp.